High Forest Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 3

  • Portfolio
  • 3

High Forest General Information

Company Description

High Forest is a venture capital firm based in London, United Kingdom. The firm focuses on early-stage companies in the biopharmaceutical industry.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 2 Merrivale Terrace
  • Distillery Road
  • London W6 9HD
  • England, United Kingdom

High Forest Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
RNAimmune 21-Apr-2021 Seed Round Drug Discovery Clinical Trials - Phase 1
Genor BioPharma 07-Oct-2020 Biotechnology Generating Revenue
Flowerstreet54 Hotels and Resorts Generating Revenue
To view High Forest’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

High Forest Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

High Forest FAQs

  • What is High Forest?

    High Forest is a venture capital firm based in London, United Kingdom.

  • Where is High Forest headquartered?

    High Forest is headquartered in London, United Kingdom.

  • How many investments has High Forest made?

    High Forest has made 3 investments.

  • What has High Forest invested in?

    High Forest has made numerous investments in companies like RNAimmune, Genor BioPharma, and Flowerstreet54 within the Drug Discovery, Biotechnology, and Hotels and Resorts industries.

  • What has High Forest invested in recently?

    High Forest's latest investment was on 21-Apr-2021 in RNAimmune, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process